Schizophrenia: Do we really need placebo-controlled studies?

By Storosum J.G.   Elferink A.J.A.   van Zwieten B.J.  

European Neuropsychopharmacology, Vol. 8, Iss. 4, 1998-12 ,pp. : 279-286

Elsevier

Access to resources Recommend Favorite

Profile of Adverse Events with Duloxetine Treatment: A Pooled Analysis of Placebo-Controlled Studies

By Brunton Stephen  

Drug Safety, Vol. 33, Iss. 5, 2010-05 ,pp. : 393-407

Adis International

Access to resources Recommend Favorite

Alternatives to placebo-controlled trials in psychiatry

By Montgomery S.A.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 265-269

Elsevier

Access to resources Recommend Favorite

Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) - Acute placebo-controlled sleep laboratory studies with clonazepam

By Saletu M.   Anderer P.   Saletu-Zyhlarz G.   Prause W.   Semler B.   Zoghlami A.   Gruber G.   Hauer C.   Saletu B.  

European Neuropsychopharmacology, Vol. 11, Iss. 2, 2001-04 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite

An Evaluation of the Cardiovascular Safety Profile of Duloxetine: Findings from 42 Placebo-Controlled Studies

By Wernicke Joachim  

Drug Safety, Vol. 30, Iss. 5, 2007-01 ,pp. : 437-455

Adis International

Access to resources Recommend Favorite